The average length of stay for malignant neoplasm of skin in French hospitals is forecasted to remain constant at 3 days from 2024 to 2028. This trend reflects a stabilization following previous years, including 2023, where the average length of stay was already at this 3-day mark. Given the absence of variation from 2024, there is no percentage change to report over the forecasted years or compounded annual growth as the figure is constant.
Future trends to watch for include potential innovations in treatment methods which could affect the length of hospital stays, such as enhanced outpatient care or advanced non-invasive therapies. Monitoring healthcare policy changes and hospital management efficiencies in France could also impact these projections.
